Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol for Prevention of Paclitaxel-Induced Neuropathy in Breast Cancer
NCT05298696Phase 2Completed
- Sponsor
- Mansoura University
- Start
- Mar 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cilostazol in peripheral neuropathy, sponsored by Mansoura University. Started Mar 2022; status: completed.
02
Drugs
cilostazol
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT05298696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05298696.